ACID NEUTRALIZATION AND DISPOSAL IN GASTRIC EPITHELIUM
Project Number5R29DK044571-05
Contact PI/Project LeaderSOYBEL, DAVID I
Awardee OrganizationBRIGHAM AND WOMEN'S HOSPITAL
Description
Abstract Text
Previous studies have indicated that the gastric mucosa normally is
protected from the damaging effects of luminal acid by preventing diffusion
of acid from the lumen into the mucosa and neutralizing or disposing of H+
ions entering the tissue. Impairment of these protective properties,
rather than hypersecretion of acid is generally held to be the cause of
acute mucosal erosions elicited by topical agents of injury or systemic
sepsis or stress. Recent work in isolated gastric epithelial systems,
however, has suggested: 1) that transport and permeability processes
located in the basolateral (i.e. serosal-side) cell membrane regulate
intracellular ion composition and pH; 2) that processes leading to
basolateral uptake of HCO3- or extrusion of H+ may depend substantially on
cotransport or exchange mechanisms with Na+, K+ or C1-; and 3) that topical
agents of injury such as aspirin or bile salts may not only reduce the
resistance of the epithelium to back-diffusion of acid, but they may
directly impair these cellular mechanisms of H+ neutralization or disposal.
To further define these protective mechanisms at the cellular level, the
proposed studies are designed: 1) to identify basolateral mechanisms which
regulate intracellular levels of Na+, K+ and C1-; 2) to examine the
basolateral co-transport mechanisms by which the cell uses these ions to
take up HCO3- or extrude H+ in order to preserve cell pH; 3) to evaluate
the effects of topical agents of injury on the cell's ability to handle
experimental acid loads, independent of their effects on permeability to
luminal acid. These three sets of specific aims will be pursued using
intracellular microelectrode techniques in an in vitro model of surface
epithelium from the gastric antrum of the amphibian, Necturus maculosus.
The first set will be addressed by defining the contributions of the
different permeability and transport properties which regulate
intracellular levels of Na+, K+ and C1-. These studies will also examine
the influence of changes in luminal acidity and nutrient composition on the
processes which regulate intracellular levels of these ions. The second
set of studies will be directed at identifying specific processes such as
Na+/H+ or C1-/HCO3- exchange in the cell's ability to buffer an acid load
and evaluating the dependence of these processes on intracellular ion
composition. Further studies will evaluate the influence of cellular
regulatory agents such as prostaglandin or cAMP on the cell's ability to
maintain ion composition and pH during experimental acid loading. The
final set of studies will evaluate the effects of two well known
ulcerogens, aspirin and bile salt, on processes which regulate cell ion
composition and whether alterations in these processes would impair the
cell's ability to neutralize or dispose of influxing H+ ions. The proposed
studies should provide, at the cellular level, a more detailed
understanding of the protective functions of the gastric surface epithelium
and of the disturbances of cell transport and permeability properties which
occur in different ulcerogenic conditions.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Urodelaacid base balancealternatives to animals in researchaquatic organismaspirinbasolateral membranechlorinecholanate compoundcyclic AMPelectrophysiologygastric mucosagastrointestinal epitheliumgastrointestinal pharmacologyhydrogenion transportmembrane transport proteinsmicroelectrodespotassiumprostaglandinstissue /cell cultureulcer
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
030811269
UEI
QN6MS4VN7BD1
Project Start Date
01-February-1992
Project End Date
31-January-1997
Budget Start Date
01-February-1995
Budget End Date
31-January-1996
Project Funding Information for 1995
Total Funding
$120,380
Direct Costs
$72,788
Indirect Costs
$47,592
Year
Funding IC
FY Total Cost by IC
1995
National Institute of Diabetes and Digestive and Kidney Diseases
$120,380
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R29DK044571-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29DK044571-05
Patents
No Patents information available for 5R29DK044571-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29DK044571-05
Clinical Studies
No Clinical Studies information available for 5R29DK044571-05
News and More
Related News Releases
No news release information available for 5R29DK044571-05
History
No Historical information available for 5R29DK044571-05
Similar Projects
No Similar Projects information available for 5R29DK044571-05